In addition, RNF38, an E3 for LDB1 or other substrates, has been reported to enhance 5-FU resistance in CRC, which further indicated that LDB1 may be an important mediator for drug resistance in CRC cells (22, 23). This evidence concerns the gene LDB1 and colorectal carcinoma.